Cas no 1260833-40-6 (5-Bromo-2-cyclobutoxypyrimidine)
5-Bromo-2-cyclobutoxypyrimidine Chemical and Physical Properties
Names and Identifiers
-
- 5-bromo-2-(cyclobutyloxy)Pyrimidine
- 5-Bromo-2-cyclobutoxypyrimidine
- Pyrimidine, 5-bromo-2-(cyclobutyloxy)-
- 5-Bromo-2-cyclobutoxy-pyrimidine
- APSFUHNWFXKNDL-UHFFFAOYSA-N
- SY237564
- 1260833-40-6
- AKOS013180832
- CS-0315214
- 5-bromo-2-cyclobutyloxypyrimidine
- F6608-0267
- AC3511
- DA-37888
- SCHEMBL256102
- KS-9433
- MFCD16618818
- A1-02066
-
- MDL: MFCD16618818
- Inchi: 1S/C8H9BrN2O/c9-6-4-10-8(11-5-6)12-7-2-1-3-7/h4-5,7H,1-3H2
- InChI Key: APSFUHNWFXKNDL-UHFFFAOYSA-N
- SMILES: BrC1C=NC(=NC=1)OC1CCC1
Computed Properties
- Exact Mass: 227.98983g/mol
- Monoisotopic Mass: 227.98983g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 12
- Rotatable Bond Count: 2
- Complexity: 144
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 35
- XLogP3: 2.1
5-Bromo-2-cyclobutoxypyrimidine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Apollo Scientific | OR471698-250mg |
5-Bromo-2-cyclobutoxypyrimidine |
1260833-40-6 | 95% | 250mg |
£200.00 | 2025-02-20 | |
| Apollo Scientific | OR471698-1g |
5-Bromo-2-cyclobutoxypyrimidine |
1260833-40-6 | 95% | 1g |
£449.00 | 2025-02-20 | |
| Apollo Scientific | OR471698-5g |
5-Bromo-2-cyclobutoxypyrimidine |
1260833-40-6 | 95% | 5g |
£831.00 | 2025-02-20 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | Y16375-250mg |
5-bromo-2-(cyclobutyloxy)Pyrimidine |
1260833-40-6 | 95% | 250mg |
¥1359.0 | 2023-09-05 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | Y16375-5g |
5-bromo-2-(cyclobutyloxy)Pyrimidine |
1260833-40-6 | 95% | 5g |
¥6879.0 | 2023-09-05 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | Y16375-1g |
5-bromo-2-(cyclobutyloxy)Pyrimidine |
1260833-40-6 | 95% | 1g |
¥3129.0 | 2023-09-05 | |
| SHANG HAI SHAO YUAN SHI JI Co., Ltd. | SY237564-0.25g |
2-[5-[(3-Methyl-3-oxetanyl)methoxy]-1-benzimidazolyl]-8-quinolinol |
1260833-40-6 | ≥95% | 0.25g |
¥900.0 | 2023-09-15 | |
| SHANG HAI SHAO YUAN SHI JI Co., Ltd. | SY237564-1g |
2-[5-[(3-Methyl-3-oxetanyl)methoxy]-1-benzimidazolyl]-8-quinolinol |
1260833-40-6 | ≥95% | 1g |
¥2080.0 | 2023-09-15 | |
| SHANG HAI SHAO YUAN SHI JI Co., Ltd. | SY237564-5g |
2-[5-[(3-Methyl-3-oxetanyl)methoxy]-1-benzimidazolyl]-8-quinolinol |
1260833-40-6 | ≥95% | 5g |
¥4580.0 | 2023-09-15 | |
| TRC | B284185-250mg |
5-Bromo-2-cyclobutoxypyrimidine |
1260833-40-6 | 250mg |
$ 310.00 | 2022-06-07 |
5-Bromo-2-cyclobutoxypyrimidine Related Literature
-
Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
-
Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
-
Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
-
Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
-
Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
Additional information on 5-Bromo-2-cyclobutoxypyrimidine
5-Bromo-2-cyclobutoxypyrimidine (CAS No. 1260833-40-6): A Versatile Building Block in Modern Pharmaceutical and Organic Synthesis
The compound 5-Bromo-2-cyclobutoxypyrimidine (CAS No. 1260833-40-6) is a highly specialized pyrimidine derivative that has garnered significant attention in the fields of medicinal chemistry and organic synthesis. With its unique structural features, this compound serves as a critical intermediate in the development of novel therapeutic agents and advanced materials. The presence of both a bromine substituent and a cyclobutoxy group on the pyrimidine ring makes it a valuable scaffold for further functionalization, enabling researchers to explore a wide range of chemical transformations.
In recent years, the demand for heterocyclic compounds like 5-Bromo-2-cyclobutoxypyrimidine has surged due to their pivotal role in drug discovery. The pyrimidine core is a common motif in FDA-approved drugs, particularly in oncology and antiviral therapies. This compound’s bromine atom offers a reactive site for cross-coupling reactions, such as Suzuki-Miyaura or Buchwald-Hartwig couplings, which are frequently employed in the synthesis of complex molecules. Its cyclobutoxy moiety further enhances its utility by introducing steric and electronic effects that can modulate biological activity.
From an industrial perspective, CAS No. 1260833-40-6 is often discussed in the context of high-value intermediates and custom synthesis. Pharmaceutical companies and contract research organizations (CROs) are increasingly seeking such building blocks to accelerate their R&D pipelines. The compound’s stability under standard storage conditions and compatibility with diverse reaction conditions make it a preferred choice for chemists working on structure-activity relationship (SAR) studies and lead optimization.
One of the trending topics in organic chemistry is the exploration of sustainable synthetic routes. Researchers are investigating greener methodologies to incorporate 5-Bromo-2-cyclobutoxypyrimidine into catalytic cycles, minimizing waste and improving atom economy. This aligns with the broader industry shift toward green chemistry and environmentally friendly processes, which are frequently searched terms in academic and industrial databases.
Another area of interest is the compound’s potential application in photopharmacology, a cutting-edge field where light-sensitive molecules are used to control drug activity with spatial and temporal precision. The bromopyrimidine scaffold, when modified, could serve as a photoswitchable moiety, opening new avenues for targeted therapies. This connects with the growing public and scientific curiosity about precision medicine and next-generation therapeutics.
For those searching “5-Bromo-2-cyclobutoxypyrimidine synthesis” or “CAS 1260833-40-6 applications”, it’s worth noting that this compound’s versatility extends beyond pharmaceuticals. It is also explored in materials science, particularly in the design of organic electronic materials and ligands for catalysis. Its electron-deficient pyrimidine ring can interact with metal centers, making it a candidate for transition-metal complexes used in homogeneous catalysis.
Quality control and analytical characterization are critical for 5-Bromo-2-cyclobutoxypyrimidine. Techniques like HPLC, NMR, and mass spectrometry are routinely employed to ensure purity and consistency, which are paramount for reproducible research outcomes. Suppliers and manufacturers often highlight these specifications to meet the stringent requirements of academic and industrial clients.
In summary, 5-Bromo-2-cyclobutoxypyrimidine (CAS No. 1260833-40-6) stands out as a multifaceted compound with broad applicability in drug discovery, materials science, and catalysis. Its unique structural attributes and compatibility with modern synthetic methods make it a staple in the toolkit of chemists worldwide. As the scientific community continues to prioritize innovation and sustainability, this compound is poised to play an even more significant role in advancing research and development across multiple disciplines.
1260833-40-6 (5-Bromo-2-cyclobutoxypyrimidine) Related Products
- 1340125-32-7(5-Bromo-2-(tetrahydro-2H-pyran-4-yloxy)pyrimidine)
- 121487-12-5(5-Bromo-2-isopropoxypyrimidine)
- 886365-64-6(5-Bromo-2-propoxypyrimidine)
- 1289027-78-6(5-Bromo-2-cyclopentyloxypyrimidine)
- 123089-12-3(5-bromo-2-(1-methyl-2-propenyloxy)pyrimidine)
- 121487-13-6(5-BROMO-2-(TERT-BUTOXY)PYRIMIDINE)
- 123089-07-6(Pyrimidine, 5-bromo-2-[(1-ethenylhexyl)oxy]-)
- 1339137-63-1(5-Bromo-2-(cyclopropylmethoxy)pyrimidine)
- 1215206-57-7(5-Bromo-2-butoxypyrimidine)
- 17758-11-1(5-Bromo-2-ethoxypyrimidine)